According to the Cuban government, one of the Covid-19 vaccines in development on the island has shown a 92 percent efficacy rate.
The developers of the three-dose Abdala vaccine said Monday that it has shown an efficacy of 92.28 percent in late-stage clinical trials.
Over the weekend, another vaccine, Soberana 2, was shown to be 62 percent effective with just two of its three doses.
“Hit by the pandemic, our scientists at the Finlay Institute and Center for Genetic Engineering and Biotechnology have risen above all the obstacles and given us two very effective vaccines,” President Miguel Diaz-Canel tweeted.
Both vaccines are expected to be granted emergency authority by local regulators shortly.